Retrospective evaluation of the predictive value of tumour burden at baseline [68 ga]ga-dota-toc or -tate pet/ct and tumour dosimetry in gep-net patients treated with prrt

HIGHLIGHTS

• What: The aim was to evaluate if tumour burden at baseline could predict treatment outcomes to PRRT with ­[177Lu]Lu-DOTA-TATE. A sensitivity analysis with exclusion of patients who did not receive all 4 planned treatments was also performed for the primary objective. In the patient cohort, the primary reason for performing Lu-DOTA-TATE SPECT/ CT imaging was to enable kidney dosimetry, but as two field of views were acquired this also allowed for evaluation of the majority of the tumours.
• Who: Anni Gålne from the Department of Medical, and have published . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.